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Abstract: Increased accumulation of indolic uremic solutes in the blood of uremic patients 
contributes to the risk of thrombotic events. Red blood cells (RBCs), the most abundant 
blood cells in circulation, may be a privileged target of these solutes. However, the effect of 
uremic solutes indoxyl sulfate (IS) and indole-3-acetic acid (IAA) on procoagulant activity 
(PCA) of erythrocyte is unclear. Here, RBCs from healthy adults were treated with IS and 
IAA (mean and maximal concentrations reported in uremic patients). Phosphatidylserine 
(PS) exposure of RBCs and their microparticles (MPs) release were labeled with Alexa Fluor 
488-lactadherin and detected by flow cytometer. Cytosolic Ca2+ ([Ca2+]) with Fluo 3/AM 
was analyzed by flow cytometer. PCA was assessed by clotting time and purified coagulation 
complex assays. We found that PS exposure, MPs generation, and consequent PCA of RBCs 
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at mean concentrations of IS and IAA enhanced and peaked in maximal uremic 
concentrations. Moreover, 128 nM lactadherin, a PS inhibitor, inhibited over 90% PCA of 
RBCs and RMPs. Eryptosis or damage, by indolic uremic solutes was due to, at least 
partially, the increase of cytosolic [Ca2+]. Our results suggest that RBC eryptosis in uremic 
solutes IS and IAA plays an important role in thrombus formation through releasing RMPs 
and exposing PS. Lactadherin acts as an efficient anticoagulant in this process. 
Keywords: indoxyl sulfate; indole-3-acetic acid; phosphatidylserine; microparticle; 
procoagulant; red blood cell 
 
1. Introduction 
Uremia is characterized by the retention of several metabolites (collectively termed here as uremic 
solutes or uremic toxins). Based on the ability of these solutes to undergo clearance with dialysis, they 
are classified into three groups: small water-soluble molecules, middle molecules, and protein-bound 
solutes [1]. Indoxyl sulfate (IS) and indoxyl-3-acetate acid (IAA), two of protein-bound solutes, which 
are tryptophan metabolites derived from indole, are poorly removed by conventional dialysis and present 
a particular risk for uremic thrombophilia and accelerated atherosclerosis [2]. 
Recent studies have revealed that indolic solutes (IS and IAA) may enhance thrombosis through 
induce tissue factor (TF) in both endothelial cells (ECs) and vascular smooth muscle cells (vSMCs) [3,4]. 
However, as the most abundant cells in circulating blood, red blood cells (RBCs) are not innocent 
bystanders of hemostasis and thrombosis [5,6]. They are in permanent contact with uremic retention 
solutes and could be a privileged target of these solutes. The effects of indolic solutes, specifically on 
procoagulant activity (PCA) of RBC are still not well understood. 
Phosphatidylserine (PS), an anionic phospholipid, is usually confined to the inner leaflet of the cell 
membrane [7]. During cell injury, apoptosis, or activation, PS is externalized to the outer membrane and 
accompanied with vesicles release, also called microparticles (MPs), which expose PS and express 
membrane antigens on their surfaces [8,9]. Moreover, under the stimulation of anticarcinogenic drugs 
such as PRIMA-1 and alantolactone et al., RBC may enter suicidal death or eryptosis, which is 
characterized by cell shrinkage and cell membrane scrambling with PS exposure at the RBC  
surface [10,11]. PS is necessary for assembly of tenase and prothrombinase that results in thrombin 
generation [12]. Lang et al. (2013) reported that IS can induce PS translocation to the external surface 
of the RBC membrane [13], however, the implications of PS-externalized RBCs in PCA and subsequent 
thrombus formation were not addressed. Therefore, we investigated whether PS on RBC and  
RBC-derived MPs (RMPs) contributes to indolic solutes-associated thrombophilia. 
Lactadherin, a sensitive probe for PS exposure and an anticoagulant by competing with factors V and 
VIII for PS-containing membranes, is independent of Ca2+ and membrane PE content [14–17].  
In the present study, lactadherin was used as a novel probe for the detection of PS exposure and RMPs 
release, and an anticoagulant for inhibition of the PCA of RBC in this study. 
In this study, an integrated assessment of indolic solutes (IS and IAA) enhanced thrombogenicity was 
performed. We measured the levels of PS exposure and MP release on RBC by mimicking mean and 
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maximal concentrations of IS and IAA reported in uremic patients. Of note, we examined the  
PS-dependent contribution of RMPs and RBC to thrombosis formation. 
2. Results and Discussion 
2.1. IS and IAA Induced PS Exposure and MPs Release of RBCs 
To confirm RBC damage or eryptosis in IS and IAA, we utilized Alexa Fluor 488-lactadherin to 
detect PS exposure on RBCs and RMPs release by flow cytometer. After 24 h of incubation at the mean 
and maximal concentrations of IS and IAA found in chronic kidney disease (CKD) patients, we found 
that the percentage of lactadherin+ RBC in IS (0.1 mM) was significantly higher than that in control  
(p < 0.001), with more lactadherin+ RBC in maximal levels of IS (1 mM) than that in median levels of 
IS (0.1 mM) (p < 0.001). IAA also induced a significant increase in PS exposure after 24 h of incubation 
(p < 0.001 vs. control), and which paralleled the increasing IAA concentrations (Figure 1A,B). In another 
time-response experiment, IS (1 mM) or IAA (50 μM) induced a significant increase in PS exposure 
after 4 h of incubation, and increased rapidly during the first 24 h. From 24 h to 48 h, the proportion of 
lactadherin+ RBC continued to increase slowly, while a control group was almost unchanged during  
48 h (Figure S1). 
At the same time, we analyzed RMPs shedding by flow cytometry. The level of RMPs obtained with 
IS or IAA is higher than those obtained with control (KCl for IS, ethanol for IAA), and these levels 
paralleled with uremic solutes concentrate (Figure 1C,D). 
To visually identify PS on the outer membrane of RBCs and RMPs generation, RBCs were incubated 
with Alexa Fluor 488-lactadherin and imaged on a confocal microscopy. As shown in Figure 1F,H, partly 
RBCs exhibited volume reduction from normal discocytic shapes and changed into spherocytes with 
strong green fluorescence stained by lactadherin on the outer membrane and accompanying vesiculation 
formation. IS or IAA treatment induced typical MPs generation (the arrows indicate RMPs). Only very 
little staining by fluorescence-labeled lactadherin could be detected on control RBC (Figure 1E,G), 
which is in agreement with the findings presented in the flow cytometry measurements. 
2.2. Role of Indolic Uremic Solutes on Erythrocyte Cytosolic Ca2+ Concentration 
To explore the mechanism responsible for the PS exposure of RBCs in indolic uremic solutes, further 
experiments were performed to test cytosolic Ca2+ concentration ([Ca2+]) using flow cytometry and 
results are represented by Ca2+ dependent fluorescence intensity. As illustrated in Figure 2A,B, in 
comparison to that in control conditions, median levels of IS and IAA induced a significant increase of 
erythrocyte cytosolic [Ca2+] after 24 h of incubation. Furthermore, there was a significant increase of 
[Ca2+] in maximal levels of IS (1 mM) and IAA (50 μM) than that in median uremic concentration, 
respectively (p < 0.001). 
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Figure 1. Detection of phosphatidylserine (PS) exposure and microparticles (MPs) release 
on red blood cells (RBCs). RBCs from healthy volunteers were incubated with median and 
maximal uremic concentration of IS and IAA for 24 h, respectively. KCl or ethanol was 
utilized as their respective controls. (A,B) Lactadherin-binding percent of RBCs was 
evaluated by flow cytometry. Results represent the mean ± SD of four independent 
experiments (* p < 0.001). (C,D) After indolic uremic solutes treatment for 24 h, MPs from 
10 mL of the RBCs supernatants was harvested, and stained with Alexa Fluor  
488-lactadherin and Alexa Fluor 647-CD235a. RMPs were defined as smaller than 1 μm and 
coexpression of lactadherin and CD235a. The number of RMP per μL culture medium was 
examined using flow cytometry. Results represent the mean ± SD of four independent 
experiments (* p < 0.001). PS exposure and MPs release on RBCs using confocal 
microscopy. RBCs were stained with Alexa Fluor 488-lactadherin in the dark at room 
temperature. RBC membrane displayed green fluorescence when labelled by Alexa Fluor 
488-lactadherin. Few lactadherin staining was observed on RBCs cultured in KCl (E) or 
ethanol (G). Treatment of RBCs with 1.0 mM IS (F) or 50 μM IAA (H) for 24 h led to PS 
externalized to the outer membrane, vesicles released from the budding of cellular 
membranes. Arrows indicate MP generation (appeared green) on erythrocyte membranes, 
and the stars indicate spherocyte. Bars represent 10 μm. PS, phosphatidylserine; IS, Indoxyl 
sulfate; IAA, indoxyl-3-acetate acid; RBC, red blood cell, MPs, microparticles; RMPs, RBC 
derived MPs. 
2.3. Effect of Ca2+ Withdrawal on IS and IAA Induced PS Exposure 
In order to verify whether the PS exposure on erythrocyte by indolic uremic solutes was secondary to 
an increase of [Ca2+], erythrocytes were exposed to IS (0.1 mM) and IAA (20 μM) for 24 h either in the 
presence of extracellular Ca2+ (1 mM) or in the nominal absence of Ca2+ and presence of the Ca2+ chelator 
EGTA (1 mM). As shown in Figure 3, the effect of IS and IAA on the increased PS exposure was 
virtually abolished in the absence of Ca2+. 
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Figure 2. Role of uremic solution on erythrocyte cytosolic Ca2+ concentration. Following 
exposure for 24 h to the different indicated concentration of indolic uremic solutes, 
erythrocytes were washed in Ringer solution and then loaded with Fluo 3/AM. Ca2+ 
dependent fluorescence intensity was measured with flow cytometry. The Fluo-3 mean 
fluorescence intensity (MFI) (arbitrary units) in erythrocytes exposed to culture media with 
indoxyl sulfate (IS) (A) and indoxyl-3-acetate acid (IAA) (B) was shown. Data are displayed 
as mean ± SD for triplicate samples of independent experiments, * indicate p < 0.001. 
 
Figure 3. Effect of Ca2+ withdrawal on IS and IAA induced PS exposure. The percentage of 
lactadherin binding erythrocytes after a 24 h treatment with IS (0.1 mM) or IAA  
(20 μM) in the presence and absence of EGTA (1 mM). KCl or ethanol was utilized as their 
respective controls. Data are displayed as mean ± SD for triplicate samples of independent 
experiments, * indicate p < 0.001. 
2.4. IS and IAA Increase the PCA of RBCs 
Further experiments explored whether indolic uremic solutes triggered PCA of RBCs. We first 
evaluated the PCA of RBCs and RMPs by recalcification-time assays in the absence or presence of IS 
and IAA. Incremental PCA was exhibited by reductive clotting time. As shown in Figure 4A,B, the 
coagulation time was significantly reduced in IS (0.1 mM) and IAA (20 μM) compared with RBCs in 
control medium (KCl for IS, ethanol for IAA) after 24 h of incubation (p < 0.001), with shorter 
coagulation time in maximal levels of IS (1 mM) and IAA (50 μM) than in median uremic concentration 
(p < 0.001). For RMPs, IS and IAA enhanced the PCA also in a concentration-dependent fashion. The 
reduction of coagulation time was in accord with the number of RMPs. In order to explore the 
relationship between PS exposure and PCA of RBCs that induced by IS or IAA, we performed 
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coagulation inhibition assays. PCA of both RBCs and RMPs were almost completely inhibited by 128 
nM lactadherin, as described in Figure 4C,D. 
 
Figure 4. Recalcification time and inhibition assay. RBCs were treated with different 
concentrations of IS or IAA for 24 h, cells and RMPs were collected, respectively. KCl or 
ethanol was utilized as their respective controls. Coagulation times of 100 μL RBCs  
(1 × 108) and RMPs (prepared from 10 mL of the RBCs supernatants) in each group of IS 
(A) and IAA (B) are shown. PCA of RBCs and RMPs that incubated in IS (C) and IAA (D) 
were detected in the absence or presence of 128 nM lactadherin. Data are displayed as  
mean ± SD for triplicate samples of independent experiments, * indicate p < 0.001. 
 
Figure 5. Formation and inhibition assays of procoagulant enzyme complexes. After 
exposure for 24 h to the different indicated concentration of IS or IAA or KCl (control) or 
ethanol (control), erythrocytes were washed with Ringer solution. Intrinsic FXa formation 
was measured in the presence of FIXa, FVIII and thrombin. Thrombin generation was 
investigated in the presence of FXa and FVa. Intrinsic FXa and thrombin production of 105 
RBCs in each group of IS (A) and IAA (B) are shown. The capacity of 128 nM lactadherin 
to block procoagulant enzyme complexes on RBCs that incubated in IS (C) and IAA (D) 
was evaluated. Results represent the mean ± SD for triplicate of independent experiments,  
* indicate p < 0.001. 
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We further investigated the capacity of RBCs to support intrinsic FXa and thrombin that contribute 
to PCA. As depicted in Figure 5A, the production of the two procoagulant enzyme complexes was 
increased in median uremic concentration of IS (0.1 mM) compared with controls (p < 0.001), and more 
higher in maximal levels of IS (1 mM). Similar results were obtained on IAA treated RBC, the rise of 
thrombin and intrinsic FXa production paralleled the increasing IAA concentration (Figure 5B). 
Inhibition assays of FXa and prothrombinase productions were also performed. Over 90% of the 
production of two procoagulant enzyme complexes was inhibited by 128 nM lactadherin (Figure 5C,D). 
Results from inhibition assays confirmed further that PS played a crucial role in the PCA of indolic 
uremic solutes treated RBCs. 
 
Figure 6. Mechanism diagram of indolic solutes-induced PCA of erythrocytes. IS and IAA 
triggered PS externalized on the outer membrane of RBC and accompanied with RMPs 
shedding. Externalized PS on RBCs and PS-bearing RMPs provided binding sites for FXa 
and prothrombinase complexes, increased thrombin production and enhanced thrombus 
formation. PS, phosphatidylserine; RMPs, RBC derived MPs; IS, Indoxyl sulfate; IAA, 
indoxyl-3-acetate acid; PCA, procoagulant activity. 
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2.5. Discussion 
In this study, we have found that indolic uremic solutes (IS or IAA) induced a procoagulant phenotype 
on RBC through increased PS exposure and RMP release. Exposed PS of RBCs and RMPs supports the 
assembly of intrinsic FXa and prothrombinase, moreover, blockade of PS with lactadherin inhibits 
activity of procoagulant enzyme complexes and consequently decreases the PCA of RBCs and RMPs 
(Figure 6). Furthermore, we showed that PS translocation to the RBC surface within indolic uremic 
solutes is at least partially due to increased cytosolic Ca2+ concentration. 
The protein-bound uremic solutes IS and IAA are poorly removed by conventional dialysis and 
probably contribute to cardiovascular risk during the progression of chronic kidney disease (CKD) [18]. 
RBCs could be a major concern because they make up more than 99% of the total blood cells and live 
for about 120 days in the circulation system and could be particularly deleterious in these uremic solutes. 
However, the role of erythrocyte in indolic uremic solutes-associated hemostatic disorders has not been 
fully evaluated. RBC do not express tissue factor [19]. We therefore designed this study to evaluate the 
effects of IS and IAA on PS exposure, MPs release of RBCs and consequent PCA. 
Our results showed that IS and IAA were able to induce the PS externalization and RMPs release of 
RBC. Compared with the results of Lang et al. [13], more higher levels of PS exposure on RBC was 
detected by Alexa Fluor 488-lactadherin, because lactadherin is more sensitive for detecting PS exposure 
than annexin V [16,20]. Unlike annexin V, the lactadherin assay is Ca2+ independent, making it suitable 
for our detection of PS exposure on RBC in the absence of extracelluar calcium. Under confocal 
microscopy using Alexa Fluor 488-lactadherin, we visually identify PS externalization on erythrocyte 
membranes accompanying MPs formation in uremic solutes. These erythrocytes change into spherocytes 
by a substantial loss of membrane surface through vesiculation and MPs generation. All these results 
reveal that IS and IAA trigger a suicidal erythrocyte death that is eryptosis [21,22]. 
The role of erythrocyte in indolic uremic solutes-associated hemostatic disorders has not been fully 
evaluated. Our prior research found that RBC is involved in hypercoagulability in nephrotic syndrome 
(NS) and polycythemia vera (PV) via PS exposure and MPs shedding [23,24]. In this study, we evaluated 
the prothrombotic impact of IS and IAA on RBCs. We found that the increased RMPs shedding and 
exposure of PS on the surface of RBCs provides binding sites for FXa and prothrombinase complexes, 
thus promoting the coagulation cascade reaction and subsequently leading to a dramatic increase in 
thrombin generation. In another experiment, RBCs were pre-incubated with 128 nM lactadherin, which 
inhibited over 90% production of the FXa and thrombin, and almost restored coagulation times of RBCs 
and RMPs to control levels. Therefore, strong evidence demonstrates that the PCA is mostly due to 
exposed PS on the surface of RBCs and shed RMPs. Our present study not only indicated increase of PS 
exposure and MPs release of RBC in indolic uremic solute but also confirmed one mechanism of  
IS- and IAA-induced hypercoagulable state, which may be a factor inducing cardiovascular events in 
CKD. In the present study, we examined only IS and IAA, which are known to have vascular effects, 
rather than each kind of toxin. Further studies will be necessary to investigate the role of other uremic 
solutes on RBC. 
As eryptosis is triggered by the increase of cytosolic Ca2+ concentration ([Ca2+]) [25–27], fluo3 
fluorescence was employed to estimate [Ca2+]. Our results showed that cytosolic [Ca2+] was increased 
significantly in indolic uremic solutes and associated with increased PS exposure and RMPs release. 
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Upon the increase of cytosolic [Ca2+], scramblase presumably mediate PS translocation to the 
erythrocyte surface with membrane blebbing and MPs shedding [28,29]. Removal of extracellular Ca2+ 
significantly blunted the effect of IS and IAA on lactadherin binding. Our study shows that the increased 
cytosolic [Ca2+] might contribute to IS and IAA-induced PS exposure and MPs generation in erythrocyte. 
The underlying molecular mechanism will be required to define our future studies. 
Lactadherin, an effective PS-stained reagent was used as a novel probe to quantify and localize PS 
exposure on RBC. Moreover, lactadherin acts as an effective anticoagulant for inhibiting PCA of IS- and 
IAA-cultured RBC by blocked PS, which may prevent indolic uremic solutes induced thrombophilia. 
In conclusion, we provide new insights into the roles of RBCs in the development of IS and  
IAA-related hypercoagulable states. We demonstrated that indolic uremic solutes increased PCA of RBC 
by inducing PS exposure and RMPs release, and the effect is at least partially due to increased cytosolic 
[Ca2+]. Alternatively, it is necessary to further study the possibility of applying lactadherin in thrombotic 
complications of uremia. 
3. Materials and Methods 
3.1. Reagents 
Indoxyl sulfate (IS), indole-3-acetic acid (IAA) and EGTA were obtained from Sigma (Saint Quentin 
Fallavier, France). Megamix beads (mix of 0.5, 0.9 and 3.0 μm beads) were from Biocytex (Marseille, 
France). Trucount Tube (Cat. No. 340334), Purified CD235a (clone GA-R2) and mouse IgG1/IgG2a 
(clone X40/X39) were from Becton Dickinson Biosciences (San Jose, CA, USA), and were labeled in 
our laboratory with Alexa Fluor 647 (Invitrogen, Eugene, OR, USA). Bovine lactadherin was purified 
as described previously Hvarregaard et al. (1996) [30] and were labeled in our laboratory with Alexa 
Fluor 488 (Invitrogen). Fluo 3/AM was from Biotium (Hayward, CA, USA). Human factors Va, VIIa, 
IXa, X, Xa, prothrombin and thrombin were all from Haematologic Technologies (Burlington, VT, 
USA). Recombinant human factor VIII was from American Diagnostica Inc. Chromogenic substrates  
S-2765 and S-2238 were from Instrumentation Laboratory Company (MA, USA). 
3.2. Protein Purification and Labeling 
Bovine lactadherin was purified as previously described, and was labeled with Alexa Fluor 488 
according to the package instructions. The ratio of fluorescein to lactadherin was 1.2/1 [30,31]. 
3.3. Preparation of RBCs and Treatment 
The study was approved by the Ethics Committee of Harbin Medical University and consistent with 
the Helsinki Declaration. Peripheral vein blood was drawn from each eight healthy volunteers by 
antecubital venipuncture and anticoagulated with trisodium citrate 0.109 mol/L. These healthy donors 
were 19–22 years old, sex matched, non-smokers, and they had not taken any drugs for at least  
two weeks. RBCs were prepared within 30 min after blood collection by centrifugation for 15 min at  
200 g at room temperature, and then the supernatant platelet-rich plasma (PRP) and leukocyte were 
removed carefully. IAA was diluted from a stock solution prepared in ethanol, and IS from a stock 
solution prepared in KCl. 
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Under a 5% CO2 humidified atmosphere at 37°C, RBCs (at a hematocrit of 0.4%) were maintained 
in Ringer solution (125 mM NaCl, 5 mM KCl, 1 mM MgSO4, 32 mM HEPES, 5 mM glucose and 1 mM 
CaCl2, pH 7.4) in 6-well culture plate and exposed to median and maximal uremic concentration of IS 
(0.1 mM and 1 mM) and IAA (20 μM and 50 μM) at indicated time points, respectively. Uremic solutes 
were compared with their respective controls (KCl or ethanol) diluted in the culture medium in the  
same range. In Ca2+-free Ringer solution, 1 mM CaCl2 was substituted by 1 mM glycol-bis  
(2-aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA). 
3.4. Preparation of MDP and RMPs 
For MDP preparation, PRP were centrifuged 20 min at 1500 g, and plasma was then harvested and 
centrifuged 2 min at 13,000 g to remove all residual platelets. The platelet free plasma (PFP) was 
centrifuged at 106,000 g for 1 h at 4 °C to remove MPs, aliquoted, and stored at −80 °C. RBCs in each 
well were collected by centrifugation (200 g, 15 min). The supernatants containing red blood  
cell-derived microparticles (RMPs) were harvested. As previously described [23], RMPs were pelleted 
by ultracentrifugation (106,000 g, 45 min, 4 °C) of the supernatants, and resuspended in 100 μL  
Ringer solution. 
3.5. Flow Cytometry 
To quantify PS exposure, RBCs suspended in Ringer solution were adjusted to 0.5–1 × 106/mL, then 
5 μL Alexa Fluor 488-conjugated lactadherin was added to the cell suspension respectively and 
incubated for 10 min at room temperature in the dark. Ten thousand events per sample were acquired 
and analyzed with BD FACS Diva Software. RMPs were defined as smaller than 1 μm and coexpression 
of lactadherin and CD235a. The number of RMPs per μL culture medium was calculated by Trucount 
Tube (with a precise number of fluorescent beads 48,678 to determine the number of MPs in a sample) 
after accumulation of 10,000 gated events and analyzed with Diva Software. 
3.6. Confocal Microscopy 
Observation of the PS exposure on RBCs was carried out as previously described [23]. RBCs were 
incubated with the indicated concentrations of Alexa Fluor 488-lactadherin for 10 min at room 
temperature in the dark, then washed to remove unbound dye and analyzed immediately. Images were 
obtained in LSM 510 SYSTEM (Carl Zeiss Jena GmbH, Jena, Germany). 
3.7. Measurement of Intracellular Ca2+ Concentration 
For detection of cytosolic Ca2+ concentration ([Ca2+]), each group of RBCs were washed in Ringer 
solution and then loaded with 2 μM Fluo 3/AM for 1 h at 37 °C in the dark. Subsequently, RBCs were 
washed twice and then resuspended in 200 μL Ringer solution to a final concentration of 1×106/mL. 
Ca2+ dependent fluorescence intensity was measured and analyzed with BD FACS Diva Software. 
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3.8. Procoagulant Activity and Inhibition Assays 
Procoagulant activity (PCA) of RBCs and MPs was evaluated by one-stage recalcification time assay 
in a KC4A-coagulometer (Amelung, Labcon, Heppenheim, Germany) [21]. 100 μL of RBC (1 × 108) or 
MPs-containing suspension (prepared from 10 mL of the RBCs supernatants) was incubated with 100 
μL of MDP at 37 °C. After 180 seconds, 100 μL of warmed 25 mM CaCl2 was added to start the reaction 
and the clotting time was recorded. All clotting assays were performed in triplicate. For the inhibition 
assay of coagulation time, 100 μL of RBCs or MPs suspensions were preincubated with 50 μL 
lactadherin (final concentration 128 nM) for 10 min at 37 °C. Clotting time was then recorded as above 
after addition of 100 μL MDP and 50 μL of warmed 50 mM CaCl2. 
3.9. FXa and Prothrombinase Assays 
For intrinsic factor Xa assay, a total of 105 RBCs or 100 μL of RMPs-enriched suspension was 
incubated with 1 nM FIXa, 130 nM FX, 5 nM FVIII, 0.2 nM thrombin and 5 mM Ca2+ in FXa buffer  
(1 mL 10× TBS, 200 μL 10% BSA, 8.8 mL ddH2O) for 5 min at 25 °C. The reaction was stopped by 
addition of EDTA at a final concentration of 7 mM. After the addition of 10 μL S-2765 (0.8 mM) to 
each reaction, the quantity of FXa formed was determined immediately at 405 nm in kinetic mode on a 
Universal Microplate Spectrophotometer (PowerWave XS; Bio-Tek). Results were evaluated against the 
rate of substrate cleavage of a standard dilution of FXa. For the prothrombinase assay, RBCs were 
incubated with 1 nM FVa, 0.05 nM FXa, 1 μM prothrombin and 5 mM Ca2+ in prothrombinase buffer 
(1 mL 10× TBS, 50 μL 10% BSA, 8.95 mL ddH2O) for 5 min at 25 °C. EDTA and S-2238 were added 
to each microplate, and thrombin production was assessed as previously described [21]. Inhibition assays 
of coagulation complexes by lactadherin were performed as follows. RBC was incubated with 128 nM 
lactadherin for 10 min at 25 °C in Ringer solution. The quantity of thrombin or FXa formation was then 
assessed as above. 
3.10. Statistical Analysis 
Data are expressed as mean ± standard deviation (SD), and statistical analysis was made by Wilcoxon 
or Kruskal-Wallis test as appropriate. p < 0.05 was considered statistically significant. 
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